Anthrax Antitoxins for the Treatment of Inhalational Anthrax
Award Notice Posted
- Solicitation number
- RFP-12-100-SOL-00026
- Agency
-
Immediate Office of the Secretary
Department of Health and Human Services
- Awarded
- to Altimmune, Inc.
- Set-aside
- Partial Small Business
Opportunity facts
- Contract number
- HHSO100201300012I Federal IDV award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Not on record
Notice details come from SAM.gov. Updated .
Notice text
5 versions
Update #5 · Latest ·
The purpose of this announcement is for the award of an Indefinite Delivery Indefinite Quantity (IDIQ) type contract is to acquire, store, and distribute medical countermeasures that will mitigate injuries caused by exposure to chemical, biological threat agents, physical radiologic and nuclear exposures. The Biomedical Advanced Research and Development Authority (BARDA) within the Office of the Assistant Secretary for Preparedness & Response (ASPR) has a specific need for anthrax antitoxin products to treat individuals with symptomatic anthrax disease resulting from aerosol release of Bacillus anthracis (B. anthracis) spores.
Update #4 ·
The purpose of this announcement is for the award of an Indefinite Delivery Indefinite Quantity (IDIQ) type contract to acquire, store, and distribute medical countermeasures that will mitigate injuries caused by exposure to chemical, biological threat agents, physical radiologic and nuclear exposures. The Biomedical Advanced Research and Development Authority (BARDA) within the Office of the Assistant Secretary for Preparedness & Response (ASPR) has a specific need for anthrax antitoxin products to treat individuals with symptomatic anthrax disease resulting from aerosol release of Bacillus anthracis (B. anthracis) spores.
Update #3 ·
Amendment 3 for Anthrax Antitoxins for the Treatment of Inhalational Anthrax is now posted.
Update #2 ·
Amendment 2 for Anthrax Antitoxins for the Treatment of Inhalational Anthrax is now posted.
Update #1 ·
The Department of Health and Human Services (HHS) has the responsibility of maintaining a definitive supply of medical countermeasures - or the forward deployment of same - for use in national medical emergencies declared by the Secretary of HHS.
HHS has a requirement to acquire, store, and distribute medical countermeasures that will mitigate injuries caused by exposure to chemical, biological threat agents, physical radiologic and nuclear exposures. The Biomedical Advanced Research and Development Authority (BARDA) within the Office of the Assistant Secretary for Preparedness & Response (ASPR) has a specific need for anthrax antitoxin products to treat individuals with symptomatic anthrax disease resulting from aerosol release of Bacillus anthracis (B. anthracis) spores.
Files
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity